WallStreetZenWallStreetZen

NASDAQ: TRVI
Trevi Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for TRVI

Based on 3 analysts offering 12 month price targets for Trevi Therapeutics Inc.
Min Forecast
$6.00+133.46%
Avg Forecast
$7.00+172.37%
Max Forecast
$8.00+211.28%

Should I buy or sell TRVI stock?

Based on 3 analysts offering ratings for Trevi Therapeutics Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TRVI stock forecasts and price targets.

TRVI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Needham
Bottom 12%
12
BuyReiterates$8.00+211.28%2023-05-12
B. Riley Securities
Top 2%
99
Strong BuyInitiates Coverage On$6.00+133.46%2023-04-12
JonesTrading
Bottom 17%
17
Strong BuyInitiates Coverage On$7.00+172.37%2023-03-14

1 of 1

Forecast return on equity

Is TRVI forecast to generate an efficient return?
Company
N/A
Industry
0.06%
Market
72.15%

Forecast return on assets

Is TRVI forecast to generate an efficient return on assets?
Company
N/A
Industry
0.09%

TRVI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TRVI$2.57$7.00+172.37%Strong Buy
ORMP$3.87$2.00-48.32%Hold
ABSI$1.68$9.00+435.71%Buy
ADVM$1.56$2.00+28.21%Strong Buy
PBYI$3.38$8.00+136.69%Buy

Trevi Therapeutics Stock Forecast FAQ

Is Trevi Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: TRVI) stock is to Strong Buy TRVI stock.

Out of 3 analysts, 2 (66.67%) are recommending TRVI as a Strong Buy, 1 (33.33%) are recommending TRVI as a Buy, 0 (0%) are recommending TRVI as a Hold, 0 (0%) are recommending TRVI as a Sell, and 0 (0%) are recommending TRVI as a Strong Sell.

If you're new to stock investing, here's how to buy Trevi Therapeutics stock.

What is TRVI's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: TRVI) forecast ROE is N/A, which is considered weak.

What is TRVI's Price Target?

According to 3 Wall Street analysts that have issued a 1 year TRVI price target, the average TRVI price target is $7.00, with the highest TRVI stock price forecast at $8.00 and the lowest TRVI stock price forecast at $6.00.

On average, Wall Street analysts predict that Trevi Therapeutics's share price could reach $7.00 by May 12, 2024. The average Trevi Therapeutics stock price prediction forecasts a potential upside of 172.37% from the current TRVI share price of $2.57.

What is TRVI's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: TRVI) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.09%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.